Table 2 |
|||
|
Operation time, number of ligated vessels and complications in the LigaSure and conventional ligation Group. |
|||
|
LigaSure (n = 20) |
Conventional (n = 20) |
P |
|
|
|
|||
|
Primary endpoint |
|||
|
Total operation time (min); median (range) |
56 (37-70) |
66 (48-99) |
0.001 |
|
Secondary endpoints |
|||
|
Length of operation phases (min); median (range) |
|||
|
Operation phase I |
16 (9-20) |
17 (12-28) |
N.S.a |
|
Operation phase II |
29 (17-40) |
38 (21-50) |
< 0.001 |
|
Operation phase III |
12 (7-26) |
11 (7-16) |
N.S. |
|
Number of ligated vessels; median (range) |
|||
|
Operation phase I |
1 (0-3) |
1 (0-4) |
N.S. |
|
Operation phase II |
14 (8-32) |
8 (3-12) |
< 0.001 |
|
Operation phase III |
3 |
0 |
N.S. |
|
Total |
16 (8-34) |
9 (4-16) |
< 0.001 |
|
Number of patients with complicated postoperative course |
2 |
0 |
N.S. |
|
|
|||
|
Schiphorst et al. Head & Neck Oncology 2012 4:2 doi:10.1186/1758-3284-4-2 |
|||
